FORMER ROCHE/GENENTECH EXECUTIVE, JENNIFER COOK, JOINS CONSYNSYS TECHNOLOGIES ADVISORY BOARD

Influential BioPharma Executive to Provide Strategic Guidance for Cloud-Native Manufacturing Automation Solutions Provider

CARSON CITY, NEVADA, September 1, 2023 - ConSynSys Technologies, Inc., a trailblazing provider of cloud-native software solutions for automating and controlling manufacturing processes, is thrilled to announce the appointment of Jennifer Cook, a distinguished figure in the BioPharma industry, to its Advisory Board. The appointment will be effective from September 1, 2023.

Jennifer Cook's highly successful career includes holding significant leadership positions at several renowned organizations. She most recently served as the CEO of GRAIL and held prominent roles such as Senior Vice President and Region Head of Europe at Roche Pharmaceuticals and Senior Vice President of Global Portfolio Management at Genentech. Jennifer's deep expertise and remarkable contributions have been recognized through her Healthcare Businesswomen's Association "Woman of the Year" Award in 2016 and current board memberships at Denali Therapeutics, Jazz Pharmaceuticals, and BridgeBio.

Michael Gagne, Chairman of the Board at ConSynSys, expressed his enthusiasm about Jennifer's appointment: "Jennifer brings an extensive track record of success in the Bio-Pharma industry, having run commercial and clinical operations at the regional and global levels. Her talents and experience will be invaluable as we accelerate our global expansion and continue to evolve our operations and solutions. We are extremely excited to have Jennifer on our Advisory Board and look forward to working closely with her."

ConSynSys has pioneered a revolutionary Cloud-native software platform that enables manufacturers to execute their Pharma 4.0 and Industry 4.0 automation strategies through Process Control as a Service, or ProCaaS®, as well as real-time sensor data capture, facilitating predictive maintenance to minimize manufacturing downtime. This innovative approach empowers clients to swiftly adapt to evolving business strategies while managing costs through the reduction or elimination of errors inherent in manual manufacturing processes. Customers are also better able to plan and manage manufacturing and production budgets by leveraging accessible monthly subscription plans. For more information about ConSynSys Technologies, please visit https://consynsys.com.

"I am looking forward to working with the executive team at ConSynSys as they scale global operations to deliver this innovative platform solution," said Cook. "The technology is critical for the industry to effectively leverage Pharma 4.0's automation principles, and with the highly experienced team leading the company, ConSynSys is in a good position to deliver these solutions."

As ConSynSys Technologies advances its mission to redefine manufacturing processes through innovative Cloud-native solutions, Jennifer Cook's addition to the Advisory Board will undoubtedly provide strategic insights and guidance that will shape the company's growth trajectory.

ConSynSys Technologies, Inc
1771 South Sutro Terrace
Carson City, NV 89706

For media inquiries and further information, please contact: Sam Svitenko Email: info@consynsys.com Website: https://consynsys.com

About ConSynSys Technologies, Inc:

ConSynSys Technologies, Inc is a pioneering provider of Cloud-native software solutions for manufacturing automation and process control. The company's cutting-edge platform enables real-time sensor data capture, predictive maintenance, and Process Control as a Service, empowering businesses to optimize operations and respond effectively to changing demands, while leveraging accessible subscription fees that allow customers to pay only for what they control, when they are controlling it.

This release was published on openPR.